Characteristics of Patients With Amyloidosis & Heart Failure Being Evaluated for a Heart Transplant
1 other identifier
observational
25
0 countries
N/A
Brief Summary
The purpose of this study is to describe the characteristics of patients with amyloidosis and severe heart failure being evaluated for cardiac and stem cell transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2007
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 2, 2007
CompletedFirst Posted
Study publicly available on registry
April 4, 2007
CompletedApril 4, 2007
April 1, 2007
April 2, 2007
April 3, 2007
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Patients with amyloidosis
- NYHA class III or IV heart failure
- Patients undergoing heart transplant evaluation
- Patients less than 18 years of age
You may not qualify if:
- Patients who have unstable pulse and blood pressure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc J Semigran, MD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 2, 2007
First Posted
April 4, 2007
Study Start
March 1, 2007
Study Completion
March 1, 2007
Last Updated
April 4, 2007
Record last verified: 2007-04